The infamous daughter of Sen. Joe Manchin - the same Heather Bresch whose influential pop got a university to give her an unearned MBA - is learning lessons. Whoop-de-do.
Mylan’s CEO Takes Lessons Learned From EpiPen Controversy Into Launching Of New Drug
By Jon Delano
June 12, 2018 at 7:27 pm
Full story at KDKA- TV
PITTSBURGH (KDKA) — Mylan Labs is about to launch a new drug that could revolutionize the way cancer is treated, and it could make it cheaper.
“It’s an important milestone for patients and our health care system,†says Heather Bresch. ...
It was the skyrocketing cost of Mylan’s EpiPen allergy drug a few years ago that got the company into hot water with consumers and Congress.
Bresch says they learned from it.
“EpiPen was a window into a broken system and not working for patients today, and I think that conversation has evolved tremendously,†she says today. ...
